News from the Department of Medicine

  • Sobel and Riser Spearhead Longitudinal Addiction Medicine Curriculum
    With new funding from the Substance Abuse and Mental Health Services Administration, UVM Associate Professor of Medicine Halle Sobel, M.D., and Elly Riser, M.D., UVM clinical instructor in medicine, are working to bring training on treating opioid use disorder as a chronic condition to physicians at the beginning of their careers – during medical school.
  • TGIR Hosts Virus "Slam" on 2019-nCoV
    University of Vermont scientists, physicians, and students gathered at the Larner College of Medicine February 6 for the first-ever on-campus “virus slam” hosted by the Translational Global Infectious Diseases Research Center. At the event, some twenty experts, from five UVM colleges and institutes, gave five-minute mini-talks that ranged from explaining the biochemistry of the virus’ interaction with the human immune system to interpreting the latest data from the World Health Organization.
  • Cushman Quoted in U.S. News on Blood Type & Blood Clot Risk Study
    Mary Cushman, M.D., M.Sc., UVM professor of medicine and director of the Thrombosis and Hemostasis Program at the UVM Medical Center, commented on an Arteriosclerosis, Thrombosis, and Vascular Biology study on the potential increased risk of blood clots in people with blood types A and B in U.S. News & World Report.
  • Goldman Named Inaugural Follansbee Professor
    Glenn Goldman, M.D., professor of medicine and chief of dermatology, was invested as the inaugural Rogers and Nancy Follansbee Professor of Dermatology during a formal ceremony held February 3, 2020 at the Larner College of Medicine at the University of Vermont.
  • Teaching Academy Retreat Events Focus on New Members, Awards, & Assessment
    ​The Teaching Academy at the Larner College of Medicine at the University of Vermont held its annual Snow Season Education Retreat on January 15-16, 2020 in the College’s Medical Education Center and UVM Davis Center. Highlights included an Induction Ceremony for 2019 new members and advanced members, the presentation of the annual Teaching and Education Awards, and the first annual Snow Season Debate, moderated by Professor and Chair of Pediatrics Lewis First, M.D.
  • JAMA Network Open Published Study by Plante and Silverman Covered by National Media Outlets
    (DECEMBER 4, 2019) A study published in JAMA Network Open last week and coauthored by Timothy Plante, M.D., Asst. Prof of Medicine, and Daniel Silverman, M.D., cardiology fellows, has been covered fairly widely in the media, including U.S. News & World Report, HealthDay News and Breitbart.
  • Silverman & Plante's Study Finds Link between Beta Blocker Use & Hospitalizations
    A new publication by UVM Clinical Instructor in Medicine Daniel Silverman, M.D., and Assistant Professor of Medicine Timothy Plante, M.D., M.H.S., in JAMA Network Open links use of beta-blockers to heart failure hospitalizations among those with this common “stiff heart” heart failure sub-type.
  • Cushman and Copeland Named to List of World’s Most Influential Researchers
    Two University of Vermont Larner College of Medicine faculty have been named to a list of the world’s most influential researchers, based on the number of times their published studies have been cited by other researchers over the past decade. Researchers on the list are in the top 1 percent of all scholars whose work has been cited. The prestigious Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.
  • UVM Health Network Pilot Project Offers Patients Genomic DNA Testing
    The UVM Health Network is partnering with Invitae and LunaPBC on a pilot project to offer Genomic DNA Testing to patients as part of their clinical care. The pilot program is the beginning of an effort to increase the integration of genetic disease risks into routine medical care, which holds promise for providing Vermonters with valuable information to guide their health decisions.
  • Research Excellence and Scholarship Highlighted at Annual Celebration Events
    The Larner College of Medicine's fourth annual "Celebrating Excellence in Research" series featured two days of presentations and recognition designed to highlight research performed by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.
  • Dixon Named Director of Vermont Lung Center
    Anne Dixon, M.A., BM BCh, professor of medicine and division chief of pulmonary disease & critical care medicine at the Larner College of Medicine at the University of Vermont, has been named the new director of the Vermont Lung Center.
  • Irvin & Colleagues Flavored E-Cigs & Asthma Study Covered by National Media Outlets
    (OCTOBER 15, 2019) Several news outlets recently covered a research study on flavored e-cigarettes and asthma published in Nature Scientific Reports by Larner faculty and trainees, including senior author and Professor of Medicine Charles Irvin, Ph.D. The study was funded through UVM's Tobacco Center on Regulatory Science (TCORS) grant.
  • Leahy-led Diabetes Panel Recommendations Featured in Multiple Media Outlets
    (OCTOBER 7, 2019) Coverage of recommendations from an Endocrine Society-convened panel of diabetes experts published in the Journal of the Endocrine Society and led by Professor of Medicine and Director of Endocinology, Diabetes & Metabolism John Leahy, M.D., received coverage in several media outlets.
  • FAN Program Makes It Easy for Faculty to Cross Disciplines. And It Comes with Free Lunch
    UVM’s Faculty Activity Network, or FAN, presents a unique opportunity to find collaborators in different disciplines. The program comes with a perk: a lunch in Waterman Manor after the lab session with Richard Galbraith, M.D., Ph.D., whose only cost for participants is to weather the friendly interrogation the research vice president launches at his lunch companions.
  • Menon featured in WCAX Segment on UVMMC Pulmonary Fibrosis Designation
    (AUGUST 7, 2019) Prema Menon, M.D., Ph.D., assistant professor of medicine and director of the Interstitial Lung Disease Clinic at the University of Vermont Medical Center, was featured in a WCAX-TV Channel 3 segment about the Medical Center's new designation from the Pulmonary Fibrosis Foundation as a member of their Care Center Network.
  • Eldakar-Hein and Menon Named Interim Assistant Deans for Students
    Interim Senior Associate Dean for Medical Education and Associate Dean for Students Christa Zehle, M.D., recently announced the appointments of Shaden Eldakar-Hein, M.D., M.S., associate professor of medicine, and Prema Menon, M.D., Ph.D., assistant professor of medicine, as interim assistant deans for students in the Office of Medical Student Education.
  • Jensen Appointed to Parallel Role as UVM Health Network Director of Research
    ​Gordon Jensen, M.D., Ph.D., professor of medicine and senior associate dean for research at the University of Vermont’s Larner College of Medicine, has been appointed to a parallel role as University of Vermont Health Network Director of Research by John Brumsted, M.D., CEO of the UVM Health Network.
  • Carney Appointed to Expanded Public Health, Health Policy and Senior Advisor Role
    Associate Dean for Public Health Jan K. Carney, M.D., M.P.H., has been named associate dean for public health and health policy and senior advisor to the dean. In addition, she will serve as Liaison Committee for Medical Education (LCME) faculty accreditation lead for the College’s 2021 site visit for reaccreditation.
  • Bethina Featured in Creaky Joints Regarding Arthritis in the Ankle
    (JUNE 11, 2019) Assistant Professor of Medicine and rheumatologist Narandra Bethina, M.D., is featured in an article in Creaky Joints regarding arthritis in the ankle.
  • Singh Interviewed by WCAX-VT About Proactive HIV Testing
    (MAY 29, 2019) Devika Singh, M.D., UVM assistant professor of medicine and UVM Medical Center infectious disease specialist was interviewed at the Larner College of Medicine in April for a May 29th WCAX-VT story about the need to be more proactive with HIV testing for Vermont patients.